Gene · 2021
NIH grants944
NIH grants whose papers are about the gene, through NIH's grant-paper links.
701 to 720 of 944
Download this page as JSON| Grant | Title | ENDOG papers | Newest fiscal year |
|---|---|---|---|
| R01AI040384 | Regulation of HIV-Mediated CD4 T Cell Apoptosis | 1 | 2011 |
| R01AI074949 | Roles of Dendritic Cells in Immune Regulation | 1 | 2011 |
| R01AT003623 | Colon Cancer Chemoprevention by Grape Seed Extract | 1 | 2011 |
| R01CA053791 | Repair of Endogenous Damage in Mammalian Genomes | 1 | 2011 |
| R01CA087952 | TRAIL Therapy for Rhabdomyosacrcoma | 1 | 2011 |
| R01CA089225 | Interactions of Pluronic block copolymers in drug resistant cancer | 1 | 2011 |
| R01CA093413 | Repair of Genotoxic Damage in Chromatin | 1 | 2011 |
| R01CA109389 | Specific Targets for Pancreatic Cancer Therapy | 1 | 2011 |
| R01CA115801 | Redox Modulation of Prostate Cancer | 1 | 2011 |
| R01CA118124 | Analysis of Homing Receptors in Prostate Cancer | 1 | 2011 |
| R01CA120451 | Pomegranate for Chemoprevention and Chemotherapy of Prostate Cancer | 1 | 2011 |
| R01CA121105 | SMAC in chemoprevention of colon cancer | 1 | 2011 |
| R01CA122065 | Role of Bim in mediating CAM-DR in hematopoietic tumors | 1 | 2011 |
| R01DK075476 | Role of UCP2 in Diabetic Stroke Brain | 1 | 2011 |
| R01DK075772 | Insulin stimulated ubiquitin-like modification | 1 | 2011 |
| R01DK076674 | Regulation of hepatic repair responses by metabolites of the uric acid pathway | 1 | 2011 |
| R01DK077124 | Mechanisms of microvascular damage in acute kidney injury | 1 | 2011 |
| R01DK080739 | Biomarkers of Metabolic and Vascular Risk in Obesity | 1 | 2011 |
| R01EY016240 | Discovery of Biomakers in Human Mitochondrial Disorders | 1 | 2011 |
| R01GM079393 | Role of Proline in Redox Homeostasis and Apoptosis | 1 | 2011 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2021/grants?page=36